ARTL
NASDAQ · Pharmaceuticals
Artelo Biosciences Inc
$4.12
+0.18 (+4.57%)
Open$3.85
Previous Close$3.94
Day High$4.19
Day Low$3.85
52W High$179.19
52W Low$3.45
Volume—
Avg Volume73.1K
Market Cap2.17M
P/E Ratio—
EPS$-22.97
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+281.1% upside
Current
$4.12
$4.12
Target
$15.70
$15.70
$11.87
$15.70 avg
$22.80
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 653.2K | 640.4K | 651.1K |
| Net Income | 176.4K | 175.3K | 172.4K |
| Profit Margin | 27.0% | 27.4% | 26.5% |
| EBITDA | 261.8K | 256.2K | 270.8K |
| Free Cash Flow | 66.8K | 83.8K | 75.0K |
| Rev Growth | -7.3% | -5.3% | +22.2% |
| Debt/Equity | 0.34 | 0.30 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |